Bringing safe new treatments to market requires an adaptive partner with specialist expertise.
That is why Merck offers BioReliance® – a partner for you through every step, from drug discovery to market approval, with our broad portfolio of biopharmaceutical characterization, safety testing and process development, as well as clinical and commercial biomanufacturing. Merck has experienced teams paired with operational expertise and deep regulatory understanding help you minimize risk at every step of your process.
Merck are the partner who supports you all the way – with your vital goal in mind.
The BioReliance® portfolio includes services such as:
- Validation Services
- Viral Clearance
- BioReliance® End-to-End Solutions
- BioReliance® Gene Therapy & Viral Vaccine Manufacturing and Testing Services
- BioReliance® Biosafety Testing Services
Tel: +44 (0) 151 649 4000
YOU MAY ALSO BE INTERESTED IN OUR NEWSLETTER